Select a medication above to begin.
Caplyta
lumateperone
Black Box Warnings .
Dementia-Related Psychosis
not approved for dementia-related psychosis; incr. mortality risk in elderly patients with dementia-related psychosis treated with antipsychotics; most deaths due to cardiovascular or infectious events
Suicidality
incr. suicidality risk in pediatric and young adult patients in short-term studies; monitor closely for clinical worsening, suicidality, or unusual behavior changes; not approved in peds patients
Adult Dosing .
Dosage forms: CAP: 10.5 mg, 21 mg, 42 mg
schizophrenia
- [42 mg PO qd]
- Info: periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
bipolar disorder, depressive episode
- [monotherapy]
- Dose: 42 mg PO qd; Info: for bipolar I or bipolar II disorder; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
- [valproate or lithium adjunct]
- Dose: 42 mg PO qd; Info: for bipolar I or bipolar II disorder; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
major depressive disorder, adjunct tx
- [42 mg PO qd]
- Info: periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [adjust dose amount]
- Child-Pugh Class B or C: 21 mg qd
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.